Sunshine Insurance Group
VC Fund
Beijing, China
Sunshine Insurance Group is a VC fund in Beijing focused on Health Care and Biotechnology. Sunshine Insurance Group Company Limited provides insurance products and services.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries Sunshine Insurance Group invests in
Stages Sunshine Insurance Group invests in
Countries Sunshine Insurance Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Series B
- $11M–$184M
- Series C
- $4.3M–$460M
- Series D
- $7.1M–$200M
Investment Focus
Industry
- Health Care 5 (19%)
- Biotechnology 5 (19%)
- Medical 4 (15%)
- Internet 3 (11%)
- Artificial Intelligence 3 (11%)
Stage
- Series C 12 (44%)
- Series B 7 (26%)
- Series D 3 (11%)
- Series E 2 (7%)
- Angel 1 (4%)
Country
- China 24 (89%)
- United States 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Phil Tian
Chief Data Scientist, Big Data Centre
|
Chief Data Scientist, Big Data Centre | Total investments: 0 | Find email | |
Zhang Weigong
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hugemed
|
Hugemed manufactures of medical devices and provides solutions in the field of endoscopy. | Series C / Mar 30, 2026 | |
Bang Er Orthopedic
|
Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation. | $109.8M / Series E / Nov 09, 2023 | |
Data Grand
|
Data Grand is a semantic analysis solution developer. | $91.8M / Series C / Mar 09, 2022 | |
|
Grit Science
|
Grit Science is a gene therapeutics firm, that engages in the R&D of liver genes. | $15M / Series A / Mar 02, 2022 | |
ChangXin Memory Technologies
|
ChangXin Memory Technologies specializes in manufacturing dynamic random-access memory (DRAM) semiconductor products. | $1.2B / Series C / Feb 17, 2022 | |
Zaihui
|
Zaihui is a SaaS-based data-driven marketing automation solution for local businesses that offers them with member management, precipitation members, incentive members, and mining member values. Product system offers intelligent precision marketing, integral marketing, stored-value marketing, anniversary marketing, attendant performance, thememarketing activities, and brand packaging marketing.Zaihui is headquartered in China and the company was founded in 2015. | $200M / Series D / Jan 11, 2022 | |
ImmuneOnco Biopharma
|
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M / Series C / Jan 01, 2022 | |
XuanZhu Pharma
|
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales. | $96.1M / Series B / Dec 31, 2021 | |
|
ImmuneOnco Biopharma
|
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M / Venture - Series Unknown / Dec 31, 2021 | |
Neurophth Therapeutics
|
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally. | $60M / Series C / Nov 23, 2021 | |
| See all 27 investments → | |||
Co-Investors
China Merchants Securities
3 deals together
Ant Group
2 deals together
CASH Capital
2 deals together
CCB Trust
2 deals together
CDF-Capital
2 deals together
DT Capital Partners
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sunshine Insurance Group invest in?
Sunshine Insurance Group invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Series B stage. Most of the 27 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sunshine Insurance Group's check size?
Sunshine Insurance Group typically joins rounds of $11M–$184M at Series B, $4.3M–$460M at Series C and $7.1M–$200M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sunshine Insurance Group participates in.
How do I contact Sunshine Insurance Group?
Public channels for Sunshine Insurance Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sunshine Insurance Group?
The team at Sunshine Insurance Group includes Phil Tian (Chief Data Scientist, Big Data Centre) and Zhang Weigong (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
